PALO ALTO, Calif., Aug. 29 /PRNewswire/ -- Genencor International, a Danisco company, announced today that it has received a grant from the U.S. Defense Advanced Research Projects Agency (DARPA...
Genencor Introduces World-Class Enzyme for Hydrogen Peroxide Elimination in Textile Processing PALO ALTO, Calif., June 16 /PRNewswire-FirstCall/ -- Genencor International, Inc., announced today...
Genencor Launches High-Performance Liquid Protease With Superior Cleaning Performance PALO ALTO, Calif., May 2 /PRNewswire/ -- Genencor International, Inc., announced today the availability of a...
Genencor Named One of the Bay Area's 100 Best Places to Work PALO ALTO, Calif., April 11 /PRNewswire-FirstCall/ -- Genencor International, Inc. (NASDAQ:GCOR) announced today that it was named one...
Protein Polymer Technologies and Genencor International Expand Exclusive License Agreement SAN DIEGO, March 30 /PRNewswire-FirstCall/ -- Protein Polymer Technologies, Inc. (OTC:PPTI) (BULLETIN...
Genencor International to Present at the Wells Fargo HealthCare Conference PALO ALTO, Calif., Feb. 28 /PRNewswire-FirstCall/ -- Genencor International, Inc. (NASDAQ:GCOR) today announced that...
Genencor International to Present at the BIO CEO & Investor Conference PALO ALTO, Calif., Feb. 17 /PRNewswire-FirstCall/ -- Genencor International, Inc. (NASDAQ:GCOR) today announced that the...
Genencor Reports Year and Fourth Quarter 2004 Results Record Quarterly and Full Year Product Revenues PALO ALTO, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Genencor International, Inc...
Genencor International, Inc.'s Fourth Quarter and Year-End Earnings Conference Call on the Web Has Been Canceled PALO ALTO, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Due to...
Danisco to Acquire Genencor COPENHAGEN, Denmark and PALO ALTO, Calif., Jan. 27 /PRNewswire-FirstCall/ -- Danisco A/S (Copenhagen Stock Exchange) ("Danisco"), one of the world's largest producers...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales